Tianye Wang is a graduate student majoring in Cancer Epidemiology. He was enrolled at Shanghai Medical College in 2017 and completed his undergraduate studies in preventive medicine in 2022. He participated in an internship at Novartis and gained experience in sales of targeted therapeutic drugs for bladder cancer. Wang co-authored two papers published in HIV Medicine and Open Forum Infectious Diseases. Currently, he mainly studies the molecular epidemiology of KSHV (Kaposi's Sarcoma Associated-Herpesvirus), involving systematic evolution and gene recombination. Wang has confidence in scientific research and is committed to revealing the genetic evolution and recombination history of KSHV.